GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Wright Medical Group NV (NAS:WMGI) » Definitions » Intrinsic Value: Projected FCF

Wright Medical Group NV (Wright Medical Group NV) Intrinsic Value: Projected FCF : $-5.47 (As of Apr. 26, 2024)


View and export this data going back to 2011. Start your Free Trial

What is Wright Medical Group NV Intrinsic Value: Projected FCF?

Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company. The details of how we calculate the intrinsic value of stocks are described in detail here.

As of today (2024-04-26), Wright Medical Group NV's Intrinsic Value: Projected FCF is $-5.47. The stock price of Wright Medical Group NV is $29.98. Therefore, Wright Medical Group NV's Price-to-Intrinsic-Value-Projected-FCF of today is 0.0.

The historical rank and industry rank for Wright Medical Group NV's Intrinsic Value: Projected FCF or its related term are showing as below:

During the past 12 years, the highest Price-to-Intrinsic-Value-Projected-FCF of Wright Medical Group NV was 46.81. The lowest was 0.00. And the median was 27.36.

WMGI's Price-to-Projected-FCF is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 1.69
* Ranked among companies with meaningful Price-to-Projected-FCF only.

Wright Medical Group NV Intrinsic Value: Projected FCF Historical Data

The historical data trend for Wright Medical Group NV's Intrinsic Value: Projected FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Wright Medical Group NV Intrinsic Value: Projected FCF Chart

Wright Medical Group NV Annual Data
Trend Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19
Intrinsic Value: Projected FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.09 -2.52 -6.65 -5.79 -8.94

Wright Medical Group NV Quarterly Data
Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20
Intrinsic Value: Projected FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -8.87 -8.94 -5.12 -5.84 -5.47

Competitive Comparison of Wright Medical Group NV's Intrinsic Value: Projected FCF

For the Medical Devices subindustry, Wright Medical Group NV's Price-to-Projected-FCF, along with its competitors' market caps and Price-to-Projected-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Wright Medical Group NV's Price-to-Projected-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Wright Medical Group NV's Price-to-Projected-FCF distribution charts can be found below:

* The bar in red indicates where Wright Medical Group NV's Price-to-Projected-FCF falls into.



Wright Medical Group NV Intrinsic Value: Projected FCF Calculation

Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company.

The details of how we calculate the intrinsic value of stocks are described in detail here.

This method smooths out the free cash flow over the past 6-7 years, multiplies the results by a growth multiple, and adds a portion of Total Stockholders Equity.

Intrinsic Value: Projected FCF = ( Growth Multiple * Free Cash Flow (6 year avg) + 0.8 * Total Stockholders Equity (most recent) ) / Shares Outstanding (Diluted Average)

In the case of negative Total Stockholders Equity, the following formula is used (see Explanation section below for the reason):

Intrinsic Value: Projected FCF = ( Growth Multiple * Free Cash Flow (6 year avg) + Total Stockholders Equity (most recent) / 0.8 ) / Shares Outstanding (Diluted Average)


Add all the Free Cash Flow together and divide 6 will get Wright Medical Group NV's Free Cash Flow(6 year avg) = $-146.21.

Wright Medical Group NV's Intrinsic Value: Projected FCF for today is calculated as

Intrinsic Value: Projected FCF=(Growth Multiple*Free Cash Flow (6 year avg)+Total Stockholders Equity (Sep20)*0.8)/Shares Outstanding (Diluted Average)
=(9.5203515959648*-146.2096+854.251*0.8)/129.463
=-5.47

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Wright Medical Group NV  (NAS:WMGI) Intrinsic Value: Projected FCF Explanation

The growth multiple is capped between 8.35 and 17.74.

Total Stockholders Equity weighting is more art than science and it should always be revisited in more detail when researching a company. Weightings from 0% to 100% to more than 100% are possible. 80% was chosen as a happy median after taking the above ideas into consideration.

Wright Medical Group NV's Price-to-Intrinsic-Value-Projected-FCF for today is calculated as

Price-to-Intrinsic-Value-Projected-FCF=Share Price/Intrinsic Value: Projected FCF
=29.98/-5.4731158609439
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Wright Medical Group NV Intrinsic Value: Projected FCF Related Terms

Thank you for viewing the detailed overview of Wright Medical Group NV's Intrinsic Value: Projected FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Wright Medical Group NV (Wright Medical Group NV) Business Description

Traded in Other Exchanges
N/A
Address
Prins Bernhardplein 200, Amsterdam, NLD, 1097 JB
Wright Medical Group develops medical devices and products in five categories: lower extremities, upper extremities, biologics, large joints, and sports medicine, and other. Products for lower extremities include joint implants and bone fixation devices for the foot and ankle, whereas products for upper extremities include implants and devices for the shoulder, elbow, wrist, and hand. The biologics business sells products used to treat damaged or diseased bone, tendons, and soft tissues or to stimulate bone growth. The large joints business sells hip and knee replacement implants. The firm's sports medicine products are used to mechanically repair tissue injuries. Wright Medical Group generates the majority of its revenue in the United States.
Executives
Steven P. Wallace officer: President, International 1023 CHERRY ROAD MEMPHIS TN 38117
Barry J. Regan officer: SVP, Operations 1023 CHERRY ROAD, MEMPHIS TN 38117
Kevin C. Smith officer: SVP, Quality and Regulatory 1023 CHERRY ROAD MEMPHIS TN 38117
Jason D. Asper officer: SVP, Chief Digital Officer 1023 CHERRY ROAD MEMPHIS TN 38117
Tim Lanier officer: President, Upper Extremities 1023 CHERRY ROAD MEMPHIS TN 38117
Patrick Fisher officer: President, Lower Extremities 1023 CHERRY ROAD MEMPHIS TN 38117
Jonathan Wesley Porter officer: SVP, Chief Compliance Officer 1023 CHERRY ROAD MEMPHIS TN 38117
Julie Andrews officer: SVP, Global Finance 5677 AIRLINE ROAD, ARLINGTON TN 38002
Jennifer S. Walker officer: SVP, Process Improvement 5677 AIRLINE ROAD ARLINGTON TN 38002
Andrew C. Morton officer: SVP, Chief Human Resources Ofr 10910 DOMAIN DRIVE, SUITE 300, AUSTIN TX 78758
Lance A Berry officer: EVP, Chief Finan./Op. Officer 5677 AIRLINE ROAD, ARLINGTON TN 38002
Julie D. Dewey officer: SVP, Chief Comm. Officer 1023 CHERRY ROAD MEMPHIS TN 38117
Kevin D Cordell officer: EVP, Chief Global Comm Officer C/O WRIGHT MEDICAL GROUP, INC. 1023 CHERRY ROAD MEMPHIS TN 38117
Robert J Palmisano director, officer: President and Chief Executive 110 HARTWELL AVENUE, LEXINGTON MA 02173
Peter Cooke officer: Pres. Emerging Markets AUS/JAP 5677 AIRLINE ROAD ARLINGTON TN 38002

Wright Medical Group NV (Wright Medical Group NV) Headlines

From GuruFocus

Keeley Asset Management Comments on Wright Medical Group

By Sydnee Gatewood Sydnee Gatewood 01-23-2020